Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Berman

Showing results (381-390 of 459) with videos related to

Pageof 46
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 23, 2012
The role of gap junction channels during physiologic and pathologic conditions of the human central nervous systemEliseo A Eugenin, Daniel Basilio, Juan C Sáez, et al.
The Journal of Surgical Research|June 7, 2000
Mycophenolate mofetil treatment reduces atherosclerosis in the cholesterol-fed rabbitS M Greenstein, S Sun, T M Calderon, et al.
Journal of Virology|August 1, 1989
Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160P W Berman, L Riddle, G Nakamura, et al.
Transplantation Proceedings|June 24, 1998
Effect of mycophenolate mofetil on atherosclerosis in a rabbit model: initial histologic and immunohistochemical analysesT C Schreiber, S M Greenstein, D Y Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cellsSean Campbell, Linda C Burkly, Hua-Xin Gao, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Development of a single-shot subunit vaccine for HIV-1J L Cleland, M F Powell, A Lim, et al.
Molecular Immunology|July 14, 2014
Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120Rachel C Doran, Javier F Morales, Briana To, et al.
Plos One|March 21, 2015
Glycans flanking the hypervariable connecting peptide between the A and B strands of the V1/V2 domain of HIV-1 gp120 confer resistance to antibodies that neutralize CRF01_AE virusesSara M O'Rourke, Ruengpung Sutthent, Pham Phung, et al.
Frontiers in Immunology|June 4, 2019
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing AntibodiesJennie M Hutchinson, Kathryn A Mesa, David L Alexander, et al.
Nuclear Medicine and Biology|March 1, 2020
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cellsRavendra Garg, Kienna Mills, Kevin J H Allen, et al.
Pageof 46

Showing results (381-390 of 459) with videos related to

Sort By:
Pageof 46
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 23, 2012
The role of gap junction channels during physiologic and pathologic conditions of the human central nervous systemEliseo A Eugenin, Daniel Basilio, Juan C Sáez, et al.
The Journal of Surgical Research|June 7, 2000
Mycophenolate mofetil treatment reduces atherosclerosis in the cholesterol-fed rabbitS M Greenstein, S Sun, T M Calderon, et al.
Journal of Virology|August 1, 1989
Expression and immunogenicity of the extracellular domain of the human immunodeficiency virus type 1 envelope glycoprotein, gp160P W Berman, L Riddle, G Nakamura, et al.
Transplantation Proceedings|June 24, 1998
Effect of mycophenolate mofetil on atherosclerosis in a rabbit model: initial histologic and immunohistochemical analysesT C Schreiber, S M Greenstein, D Y Kim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Proinflammatory effects of TWEAK/Fn14 interactions in glomerular mesangial cellsSean Campbell, Linda C Burkly, Hua-Xin Gao, et al.
AIDS Research and Human Retroviruses|January 1, 1994
Development of a single-shot subunit vaccine for HIV-1J L Cleland, M F Powell, A Lim, et al.
Molecular Immunology|July 14, 2014
Characterization of a monoclonal antibody to a novel glycan-dependent epitope in the V1/V2 domain of the HIV-1 envelope protein, gp120Rachel C Doran, Javier F Morales, Briana To, et al.
Plos One|March 21, 2015
Glycans flanking the hypervariable connecting peptide between the A and B strands of the V1/V2 domain of HIV-1 gp120 confer resistance to antibodies that neutralize CRF01_AE virusesSara M O'Rourke, Ruengpung Sutthent, Pham Phung, et al.
Frontiers in Immunology|June 4, 2019
Unusual Cysteine Content in V1 Region of gp120 From an Elite Suppressor That Produces Broadly Neutralizing AntibodiesJennie M Hutchinson, Kathryn A Mesa, David L Alexander, et al.
Nuclear Medicine and Biology|March 1, 2020
Comparison of various radioactive payloads for a human monoclonal antibody to glycoprotein 41 for elimination of HIV-infected cellsRavendra Garg, Kienna Mills, Kevin J H Allen, et al.
Pageof 46